Back to School: How biopharma can reboot drug development. Access exclusive analysis here

OSI proposes note deal

OSI (NASDAQ:OSIP) proposed to raise $150 million through the sale

Read the full 105 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE